Melanoma Cells Can Adopt the Phenotype of Stromal Fibroblasts and Macrophages by Spontaneous Cell Fusion in Vitro by Kemény, Lajos Vince et al.
 International Journal of 
Molecular Sciences
Article
Melanoma Cells Can Adopt the Phenotype of
Stromal Fibroblasts and Macrophages by
Spontaneous Cell Fusion in Vitro
Lajos V. Kemény 1,†, Zsuzsanna Kurgyis 1,†, Tünde Buknicz 1, Gergely Groma 2, Ádám Jakab 1,
Kurt Zänker 3, Thomas Dittmar 3, Lajos Kemény 1,2,*,‡ and István B. Németh 1,*,‡
1 Department of Dermatology and Allergology, University of Szeged, Szeged 6720, Hungary;
kemeny.lajos@gmail.com (L.V.K.); kurgyis.zsuzsanna@med.u-szeged.hu (Z.K.);
buknicz.tunde@med.u-szeged.hu (T.B.); yakoo@freemail.hu (A.J.)
2 MTA-SZTE Dermatological Research Group, Szeged 6720, Hungary; groma.gergo@gmail.com
3 Institute of Immunology & Experimental Oncology, Witten/Herdecke University, Witten 58453, Germany;
kurt.zaenker@uni-wh.de (K.Z.); thomas.dittmar@uni-wh.de (T.D.)
* Correspondence: kemeny.lajos@med.u-szeged.hu (L.K.); nemeth.istvan.balazs@med.u-szeged.hu (I.B.N.);
Tel.: +3662545277 (L.K. & I.B.N.)
† Lajos V. Kemény and Zsuzsanna Kurgyis contributed equally to this work.
‡ Lajos Kemény and István B. Németh contributed equally to this work.
Academic Editor: Anthony Lemarié
Received: 31 March 2016; Accepted: 17 May 2016; Published: 2 June 2016
Abstract: After the removal of primary cutaneous melanoma some patients develop local recurrences,
even after having histologically tumor-free re-excision. A potential explanation behind this
phenomenon is that tumor cells switch their phenotype, making their recognition via standard
histopathological assessments extremely difficult. Tumor-stromal cell fusion has been proposed as a
potential mechanism for tumor cells to acquire mesenchymal traits; therefore, we hypothesized
that melanoma cells could acquire fibroblast- and macrophage-like phenotypes via cell fusion.
We show that melanoma cells spontaneously fuse with human dermal fibroblasts and human
peripheral blood monocytes in vitro. The hybrid cells’ nuclei contain chromosomes from both
parental cells and are indistinguishable from the parental fibroblasts or macrophages based on
their morphology and immunophenotype, as they could lose the melanoma specific MART1
marker, but express the fibroblast marker smooth muscle actin or the macrophage marker CD68.
Our results suggest that, by spontaneous cell fusion in vitro, tumor cells can adopt the morphology
and immunophenotype of stromal cells while still carrying oncogenic, tumor-derived genetic
information. Therefore, melanoma–stromal cell fusion might play a role in missing tumor cells
by routine histopathological assessments.
Keywords: cell fusion; spontaneous melanoma; macrophage; fibroblast
1. Introduction
An increasing body of evidence indicates that cell fusion has not only a physiological role during
tissue development and repair, but might also be a hidden force promoting tumor progression [1–5].
Fibroblasts, mesenchymal stem cells, and macrophages have been proposed as fusion partners of
tumor cells [6–8]. Several studies have demonstrated that tumor-stromal hybrid cells can display more
malignant properties than parental tumor cells [9,10], and the potential contribution of cell fusion to
tumor heterogeneity has been suggested [11–14].
Most cell fusion studies are based on experiments on hybrid cells that originate from a single
hybrid clone generated with electro- or chemical fusion followed by antibiotic selection. There are
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only a few studies focusing on spontaneous cell–cell fusion, which is a well-programmed event that
requires a specific controlling system [15]. By artificially generating hybrid cells, there is the possibility
that unique and important characteristics of hybrid cells might not be discovered. Furthermore,
precise analysis of hybrid cell morphology and phenotype might also differ in a spontaneous and
programmed event.
Terada et al. showed that bone-marrow-derived stem cells can adopt the phenotype of other cells
by cell fusion [16]. Therefore, we hypothesized that tumor cells could adopt a stromal phenotype
by fusing with peritumoral fibroblasts and macrophages and thus could become indistinguishable
from tumor-associated fibroblasts and macrophages in the neighboring stroma. The detection of these
“stealthy” tumor-stromal cell hybrids could have important diagnostic and therapeutic significance.
For this reason, our aim was to establish a cell fusion model that is suitable for the characterization of
spontaneously generated hybrid cells in tumorous diseases.
2. Results
2.1. Melanoma Cells Spontaneously Fuse with Fibroblasts and Monocytes in Vitro
In order to investigate tumor–stromal cell fusion, we co-cultured various human melanoma cell
lines either with primary human dermal fibroblasts or with freshly isolated human monocytes for
24 h. CellTracker Orange (CTO) and CellTracker Green (CTG) fluorescent vital dyes were used to
identify melanoma cells and fibroblasts or monocytes, respectively (Figure 1). After 24 h, we observed
the spontaneous formation of hybrid cells containing both CTO and CTG with laser scanning
confocal microscopy. The subsequent three-dimensional reconstruction of such double positive cells
demonstrated that the double fluorescence was detected in a single cell and not from two overlapping
cells (Figure 2a,b and Supplementary Videos 1 and 2). To further confirm the fusion of melanoma
cells and stromal cells at the genetic level, we used parental cells from donors of different genders and
performed fluorescent in situ hybridization targeting the X and Y chromosomes in the hybrid cells to
visualize and distinguish genetic material from both parental cells. For these experiments, A375 female
melanoma cells were co-cultured with fibroblasts or monocytes from a male donor. A representative
hybrid cell from each co-culture containing the sex chromosomes from both parental cells is displayed
in Figure 2c,d. As also shown in Figure 2c, fluorescent in situ hybridization was performed on cell
that has been previously identified as a hybrid cells containing both CTO and CTG, suggesting that
both methods can identify the same hybrid cell. Fluorescent, four-dimensional, live-cell imaging
also confirmed spontaneous cell fusion between a monocyte and a melanoma cell (Supplementary
Video 3). The proportion of hybrid cells in the different melanoma cell lines was measured using
flow cytometry and varied between 0.17%–0.31% and 0.5%–4.39% for fibroblasts and monocytes,
respectively (Figure 2e and Supplementary Figures S1 and S2).
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Figure 2. Melanoma cells spontaneously fused with primary human dermal fibroblasts and 
monocytes. (a,b) A melanoma (CTO)–fibroblast (CTG) (a) and a melanoma (CTO)–monocyte (CTG) 
(b) hybrid visualized with a confocal microscope in X-Y and X-Z planes. The Z-stacking confirms that 
double positivity does not result from cells lying on each other. Black arrows indicate the crossline of 
planes; white bars indicate 20 µm (a) and 10 µm (b). (c) A melanoma (CTO)–fibroblast (CTG) hybrid 
confirmed with confocal microscopy contains a nucleus from a female melanoma cell and another 
from a fibroblast from a male donor (upper row). Fluorescent in situ hybridization visualizing three 
X (red) and one Y (green) chromosome in the same cell (lower row). White bars indicate 30 µm (upper 
row) and 10 µm (lower row). (d) Fluorescent in situ hybridization visualizing two X (red) and one Y 
(green) chromosome in a melanoma (female)–monocyte (male) hybrid cell. White bar indicates 10 µm. 
(e) The percentage of hybrid cells compared to the total number of melanoma cells and fibroblasts or 
to the total number of melanoma cells and monocytes after 24 h of co-culture measured with flow 
cytometry. All investigated melanoma cell lines fuse spontaneously with human dermal fibroblasts 
(left panel) and peripheral blood-derived monocytes (right panel). Means of three experiments + SD 
are shown. * indicates significant differences between the marked groups. # indicates a significant 
difference between the marked group and all the other groups. p < 0.05. DAPI: 4′,6-Diamidin-2-
phenylindol. 
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2.2. Hybrid Cells Adopt the Morphology and Phenotype of Stromal Cells
In all melanoma cell lines used for co-cultures, most of the hybrid cells were indistinguishable from
fibroblasts or monocytes based merely on cell size and morphology (Figures 3 and 4). Moreover, all
hybrid cells contained one or two nuclei, but no multinucleated cells were detected. Since hybrid cells
could adopt the morphology of stromal cells and, more importantly, lose the characteristic morphology
of melanoma cells, we examined commonly used phenotypic markers to better characterize the
CTG + /CTO + hybrid cells and to investigate whether these markers enable their discrimination
from conventional stromal cells. Some melanoma–fibroblast hybrids expressed smooth muscle actin
(SMA) (Figure 5a). Similarly, some melanoma–monocyte hybrids were positive for CD68 (Figure 5b).
Furthermore, when the MART1-expressing G361 melanoma cell line was used, we detected hybrid cells
that lost the expression of MART1 (Figure 5c,d). These results provide evidence that spontaneously
formed melanoma–stromal cell hybrids can adopt the morphology and phenotype of stromal cells.
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3. Discussion
In this paper, we show that human melanoma cells fuse with primary human fibroblasts and
human peripheral blood-derived monocytes in vitro. By combining cytosolic intravital dyes and
in situ hybridization techniques, we were able to identify and track the spontaneously formed
hybrid cells between melanoma cells and primary stromal cells. This allows the studying of
individual spontaneously formed hybrid cells, which is especially interesting, as there are currently
no unique sets of markers to identify fused cells in vivo. There are only few reports on identifying
fused cells in patient’s biopsies [17,18]. These studies pre-select potential hybrid tumor cells using
immunohistological approaches and confirm cell fusion events using genetic analyses. Therefore,
further in vitro work is needed to further characterize and identify markers unique to hybrid cells that
would allow their identification in vivo as well.
We demonstrate that the fusion takes place spontaneously with fusion rates of more than 0.1%,
which are surprisingly high compared to fusion rates reported in previous studies using electro- or
chemical fusion, followed by antibiotic selection. One possible explanation for the high fusion rates
observed with flow cytometry is that most of the hybrid cells die shortly after formation [8], partly due
to mitotic stress, and they may be very sensitive to any additional stress such as antibiotics or sorting.
It should be noted that fusion rates in our hands varied significantly among different cell donors and
even cell densities. Supposing that hybrid cells are formed constantly at a similar rate in vivo in an
inflamed tumor microenvironment, even if the majority of the hybrid cells cannot survive, this rate
should be sufficient for the detection of hybrid clones in vivo.
We found that resulting hybrid cells can adopt the morphology and immunophenotype of stromal
cells. Our results are in agreement with other studies proposing that tumor–stromal cell fusion can lead
to the formation of hybrid cells displaying mesenchymal traits [6,19]. These findings highlight the fact
that hybrid cells could acquire a stromal morphology and phenotype, which is especially interesting,
as evidence for the presence of cell fusion in human cancer is from the detection of hybrid cells in
the cancer but not the stromal compartments [17,18,20]. Therefore, future investigations are needed
to determine whether cancer cell-stromal cell hybrids could be detected in the peritumoral stromal
compartments as well. However, the role of spontaneously formed hybrid cells in vivo is unknown
and needs further investigation.
Several in vitro and animal studies suggest that cell fusion might contribute to tumor progression
by promoting metastasis formation or by inducing drug resistance [14,21] and that tumor cells can
acquire stem-cell-like properties by fusing with stromal cells [6,19,22]. Therefore, cell fusion might
serve as an evolutionary mechanism for tumor cells to acquire properties that allow them to react
quickly to a changing environment, such as during chemotherapy or irradiation, or even to evade
immune recognition. The malignant behavior of these tumor–stromal hybrid cells in mice is supported
by the finding that, even though fusion hybrids of tumor cells and multipotent stromal cells first show
a predominantly mesenchymal morphology, they subsequently undergo a reversal to a cancer-like
phenotype and that these hybrid cells form invasive and metastatic tumors in mice [11]. However,
data suggest that most hybrid cells die shortly after formation and even those cells that later start to
proliferate stay in a resting state for weeks, which supports the idea of cell fusion being an anti-tumor
mechanism, which in some rare cases may give rise to clones displaying even more malignant features
than the parental tumor cells [8]. Furthermore, as our results suggest, cell fusion might provide an
alternative mechanism for phenotype switching; thus, melanoma cells could become undetectable
with standard histopathological methods that rely on the thorough examination of cell morphology
and the expression of melanocytic markers.
In conclusion, we have here provided evidence that melanoma cells can adopt the phenotype of
stromal fibroblasts and macrophages by spontaneous cell fusion in vitro. However, further studies are
needed to functionally characterize the hybrid cells, to identify similar cells in vivo, and to clarify the
role of tumor-stromal cell fusion in tumor progression.
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4. Experimental Section
4.1. Cell Culture
The human melanoma cell lines A375, G361, UACC-257, and SK-MEL-2 were kindly provided
by Krisztina Buzás. All cell lines were authenticated using short tandem repeat (STR) analysis
(Microsynth AG, Balgach, Switzerland) after finishing all experiments. Primary human monocytes
(donated by Zsuzsanna Kurgyis and Lajos V. Kemény) were obtained from peripheral blood and
isolated using MagCellect Human CD14+ Cell Isolation Kit (R&D Systems, Minneapolis, MN, USA)
following gradient centrifugation with Ficoll-Paque (GE Healthcare Life Sciences, Chalfont St Giles,
UK). Human dermal fibroblasts were obtained from healthy individuals undergoing plastic surgery
with the approval of the local institutional review board and after signing an informed consent.
Skin samples were incubated in dispase solution overnight at 4 ˝C. After the removal of the epidermis,
the dermis was incubated in a digestion medium (10.8 mg collagenase, 5 mg hyaluronidase, 0.4 mg
deoxyribonuclease, and 0.1 mL fetal bovine serum diluted in 4 mL DMEM low glucose medium) for
two hours at 37 ˝C and filtered through a 100-µm cell strainer.
Each melanoma cell line stained with 6 µmol/mL CellTracker Orange (CMTMR) was mixed either
with fibroblasts or with freshly isolated monocytes labeled with 10 and 4 µmol/mL CellTracker Green
(CMFDA, both from Life Technologies, Carlsbad, CA, USA), respectively, and grown in co-cultures
for 24 h. The fibroblast-containing co-cultures were grown in low glucose DMEM supplemented
with 5% fetal bovine serum, while the monocyte-containing co-cultures in RPMI 1640 (HEPES
modification) with 10% fetal bovine serum and 30 IU/mL GMCSF (R&D Systems). All growth
media were supplemented with 1% Penicillin/Streptomycin and 1% Glutamine. All cell culture
reagents used are products of Lonza (Basel, Switzerland), if not specified otherwise.
For confocal microscopic visualization 100,000 melanoma cells were seeded either with
200,000 fibroblasts or with 300,000 monocytes on 1-well Lab-Tek® II Chamber Slides™ (Sigma-Aldrich,
St. Louis, MI, USA); for flow cytometric analyses, 20,000 melanoma cells either with 40,000 fibroblasts
or with 60,000 monocytes were seeded onto 12-well plates (Corning, Corning, NY, USA).
4.2. Detection of Spontaneous Cell Fusion
Co-cultures fixed with 4% paraformaldehyde (PFA) were visualized with Fluoview 1000
(Olympus, Tokyo, Japan) confocal laser-scanning microscope with a 40ˆ oil immersion
objective. Excitation/emission wavelengths were 405/461, 488/519, and 543/567 nm for
41,6-diamidin-2-phenylindol (DAPI), CTG, and CTO, respectively. For Z stacking, step size was
set to 1 µm. All fluorescent image analyses and three-dimensional reconstructions were performed
with ImageJ software (National Insitutes of Health, Bethesda, MD, USA).
4.3. Fluorescent in Situ Hybridization
Hybrid cells in PFA-fixed co-cultures were identified using AxioImager.Z1 epifluorescent
microscope, AxioCamMR3 camera (both from Carl Zeiss Microscopy, Jena, Germany) and 40ˆ oil
immersion objective. Excitation/emission filters were set to 353/465, 495/519, and 558/575 nm for
DAPI, CTG, and CTO, respectively. After the removal of cover slips, samples were fixed again with
3:1 ratio of methanol and acetate acid followed by photobleaching using Suntest CPS+ Tabletop
Xenon Exposure Systems (Thermo Fischer Scientific, Waltham, MA, USA). The monocyte-containing
co-cultures were digested using 0.01N HCl, 0.005% pepsin, and fixed with PFA. All samples were
incubated in 70% formamide in 2ˆ SSC at 95 ˝C, then in 70%, 80%, and absolute alcohol each and
dried. The X and Yc dual label fluorescent probes (Reagens Ltd., Pécs, Hungary) were put on the
samples, denatured at 72 ˝C, and incubated overnight at 37 ˝C. Then, samples were washed with 0.3%
NP-40 in 2ˆ SSC and incubated in 0.3% NP-40 in 0.4ˆ SSC at 72 ˝C. FISH signals were visualized with
Fluoview 1000 confocal laser-scanning microscope. Excitation/emission wavelengths were 488/519
and 543/567 nm for X and Y chromosomes, respectively.
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4.4. Fluorescent Live Cell Imaging
Co-cultures grown for 12 h were put into the chamber of a Fluoview 10i-W confocal laser-scanning
microscope (Olympus). Excitation/emission wavelengths were 473/519 and 559/567 nm for CTG
and CTO, respectively. Five Z-stack images with 3-µm step sizes were taken every 60 min for 12 h at
90 randomly chosen regions using 60ˆmagnification.
4.5. Measurements of Cell Fusion Rates
Co-cultures fixed with PFA and stained with DAPI were analyzed in a CyFlow® Space flow
cytometer (Sysmex Partec GmbH, Görlitz, Germany). DAPI, CellTracker Green, and CellTracker
Orange were detected on channels FL10, FL1, and FL12, respectively. Gating is shown in Figure S3.
Assuming that double positive cells in a co-culture result not only from cell fusion, we used transwell
cultures for controls, in which monocytes or fibroblasts were separated from melanoma cells by a
Transwell® (Corning) with a pore size of 3.0 µm; thus, small, stained dead cell particles could cross the
membrane but intact cells could not fuse. Therefore, fusion rate was determined as the rate of double
positive cells detected in transwell cultures subtracted from that of co-cultures. All data were analyzed
using FlowJo software (FlowJo, Ashland, OR, USA).
4.6. Immunofluorescent Staining
Co-cultures were fixed with PFA. High (for MART1) or low (for CD68) pH target retrieval solution
(DAKO, Glostrup, Denmark) was used for heat-induced epitope retrieval; for SMA staining, 0.02%
Triton-X was used as penetration enhancer. 50% heat-inactivated serum of the monocyte donor was
used to block Fc receptors on monocytes and 1% goat serum to prevent the nonspecific binding
of the secondary antibody. MART1 (clone 103, 1:200), SMA (clone 1A4, 1:200), and CD68 (clone
PG-M1, 1:100) mouse monoclonal antibodies (all from DAKO) and their appropriate isotype controls:
mouse anti-human IgG1, IgG2a, and IgG3 (all from Biolegend, San Diego, CA, USA) were labeled
with goat anti-mouse Alexa 647 antibody (Life Technologies, 1:400). All the reagents were diluted in
tris-buffered saline containing 1% bovine serum albumin and, for monocyte-containing co-cultures,
50% heat-inactivated serum of the monocyte donor.
Immunofluorescent stainings were visualized with epifluorescent microscopy. Excitation/emission
filters were set to 653/668 nm for Alexa 647.
4.7. Statistical Analysis
One-way analysis of variance and Bonferroni post hoc tests were used to compare the means of
fusion rates in different melanoma cell lines.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/
17/6/826/s1.
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